Biologos: Ampersand Capital Partners Acquiring Biological Solutions Company Biologos

Private equity firm Ampersand Capital Partners announced the acquisition of Biologos LLC, a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. This partnership with Ampersand will include investments for expanding Biologos' capabilities, product offerings, and geographic reach to support its global cell and gene therapy, biopharmaceutical, tissue processing, and animal health customers. The post Ampersand Capital Partners Acquiring Biological Solutions Company Biologos appeared first on Pulse 2.0.